Trials / Enrolling By Invitation
Enrolling By InvitationNCT06373575
IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure
Inferior Vena Cava and Lung Ultrasound B-lines Guided Decongestion in Critically Ill Kidney Failure Patients With Heart Failure: a Single-center, Prospective, Randomized Controlled Intervention Study
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this trial are to determine whether, in critically ill ESKD patients randomization to fluid removal guided by lung and inferior vena cava ultrasound, compared to standard care, leads to Improved pulmonary congestion (primary outcome); and safety (secondary outcome) in the short-term.
Detailed description
The point-of-care ultrasound was thought useful in the management of fluid in critically ill patients. At present, the role of the lung and inferior vena cava ultrasound is unclear in the management of decongestion of heart failure in kidney failure (KF) patients using prolonged hemodialysis. The investigators aim to explore the effect of pre-dialysis probing with the lung and inferior vena cava to guide fluid removal as compared with conventional protocols on the improvement of heart failure symptoms in patients with KF with heart failure under prolonged hemodialysis in the short-term.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lung and inferior vena cava ultrasound guidance | The lung and inferior vena cava ultrasound will be utilized as guidance for the development of a dialysis prescription for prolonged hemodialysis. |
| PROCEDURE | Conventional protocol guidance | Fluid removal using conventional protocol including blood pressure and physical examination |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2025-04-30
- Completion
- 2025-06-30
- First posted
- 2024-04-18
- Last updated
- 2024-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06373575. Inclusion in this directory is not an endorsement.